Faculty Publications

A Phase II Trial of Combination Bortezomib (Velcade (R)) and Rituximab for Untreated "High Tumor Burden" Indolent Non-Hodgkin Lymphoma (NHL)

David KA, Smith MR, Lossos IS, Roubal E, Winter JN, Rosen ST, Gordon LI, Evens AM

A Phase II Trial of Combination Bortezomib (Velcade (R)) and Rituximab for Untreated "High Tumor Burden" Indolent Non-Hodgkin Lymphoma (NHL)

2008;:699.

Abstract

Last updated on Saturday, November 21, 2009